ETON — Eton Pharmaceuticals, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2018-11-13.
Performance
Technicals
Others in Healthcare
Measured signals that fired on ETON
| date | signal | measured base rate |
|---|---|---|
| 2026-08-19 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-08-14 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-08-14 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-07-29 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-07-15 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-05-26 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-20 | BRYNJELSEN SEAN President & CEO | Open-market sale | 47.3K | 60.17 | 2.8M |
| 2026-08-20 | BRYNJELSEN SEAN President & CEO | Open-market sale | 36.4K | 61.11 | 2.2M |
| 2026-08-20 | BRYNJELSEN SEAN President & CEO | Open-market sale | 7.3K | 62.12 | 456.1K |
| 2026-08-19 | BRYNJELSEN SEAN President & CEO | Open-market sale | 9.0K | 62.65 | 562.5K |
| 2026-07-14 | Opaleye Management Inc. 10% owner | Open-market sale | 15.0K | 37.54 | 563.1K |
| 2026-07-14 | Opaleye Management Inc. 10% owner | Open-market sale | 15.0K | 37.54 | 563.1K |
| 2026-07-14 | Opaleye Management Inc. 10% owner | Open-market sale | 13.3K | 37.54 | 499.9K |
| 2026-07-14 | Opaleye Management Inc. 10% owner | Open-market sale | 13.3K | 37.54 | 499.9K |
| 2026-07-14 | BRYNJELSEN SEAN President & CEO | Option exercise | 200.0K | 1.37 | 274.0K |
| 2026-07-12 | BRYNJELSEN SEAN President & CEO | Option exercise | 27.5K | — | — |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Opaleye Management Inc. | 70.6M | 2.9M |
| EcoR1 Capital, LLC | 53.6M | 2.2M |
| BlackRock, Inc. | 42.4M | 1.7M |
| Nantahala Capital Management, LLC | 29.0M | 1.2M |
| VANGUARD CAPITAL MANAGEMENT LLC | 24.5M | 994.1K |
| GEODE CAPITAL MANAGEMENT, LLC | 14.3M | 577.7K |
| STATE STREET CORP | 13.1M | 530.2K |
| National Philanthropic Trust | 12.1M | 492.1K |
| MORGAN STANLEY | 11.8M | 478.0K |
| Westside Investment Management, Inc. | 11.5M | 467.9K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Eton Pharmaceuticals (ETON) Q2 2026 Earnings Call Transcript · 2026-08-20
- Why Eton Pharmaceuticals (ETON) Is Up 32.0% After Q2 Earnings Surge And Raised 2026 Outlook - simplywall.st · 2026-08-16 · simplywall.st
- Why Eton Pharmaceuticals Is Top of the Class Today · 2026-08-14
- Eton Pharmaceuticals Soars 39% After Earnings Beat and Upgraded Guidance - finance.biggo.com · 2026-08-14 · finance.biggo.com
- Why is Eton Pharmaceuticals stock surging today? · 2026-08-14
- Why is Eton Pharmaceuticals stock surging today? - Investing.com · 2026-08-14 · Investing.com
Ask the AI about ETON
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →